Emerging biologics in the treatment of uveitis. - Wikidata - wikimedia - TriplyDB

Emerging biologics in the treatment of uveitis.

Emerging biologics in the treatment of uveitis.

http://www.wikidata.org/entity/Q37754665

about

AAV2-mediated subretinal gene transfer of hIFN-α attenuates experimental autoimmune uveoretinitis in mice.

P2860

Q33911304-8FD7A593-96F8-4CB1-A9F0-5944240C72AF

P2860

Emerging biologics in the treatment of uveitis.

http://www.wikidata.org/entity/Q37754665

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emerging biologics in the treatment of uveitis.

@en

Emerging biologics in the treatment of uveitis.

@nl

type

label

Emerging biologics in the treatment of uveitis.

@en

Emerging biologics in the treatment of uveitis.

@nl

prefLabel

Emerging biologics in the treatment of uveitis.

@en

Emerging biologics in the treatment of uveitis.

@nl

P1433

Q37754665-B83F778B-E324-43E8-9E30-FDF8B0B9D50C

P1476

Q37754665-FF31FD11-26AE-470E-9C03-0961D34795EB

P2093

Q37754665-E973DED1-B1FE-4497-825C-C2198FC4EEE4

P2860

Q37754665-018D4C66-781C-4739-83E1-802BDFD0DD69

Q37754665-04D16589-BD10-4792-A11D-B51DFC176F2B

Q37754665-0855EA7D-5F58-42B4-86E1-1FEC4FCAE8FE

Q37754665-0A81FA5A-474D-4B02-9001-C36DDCAEA597

Q37754665-0ADDD857-0534-4643-8DBE-7C7B45A3FCC9

Q37754665-0AFCC0AD-40EB-41F6-A5FE-7BED788D4A0B

Q37754665-0F741B88-183D-4F3F-9AF8-45204C1F7F84

Q37754665-11DCD0AF-35AD-4358-95C9-03377E04A7E4

Q37754665-126906D9-167F-43B8-8291-C4BA7BA5825B

Q37754665-13E2E111-B86A-4CB1-A7E6-C9009C4DAB5F

P304

Q37754665-EDD6C773-F061-4033-A286-52F1CC5A1A80

P31

Q37754665-BCD30CDC-740A-4051-A12E-B8DCCB882571

P356

Q37754665-7F086BBA-1612-448E-A454-9A60606BFF8C

P433

Q37754665-55014431-1378-4DA2-B38B-0FF98D9A536E

P478

Q37754665-2A29BAF5-293C-4722-9063-C0DC047FD214

P50

Q37754665-54652BD6-F2D9-44F1-9EB8-A6FA00959D78

Q37754665-705F8DA1-0FF1-4751-B062-477C236C9D79

P577

Q37754665-7FF42B03-4F42-440A-8BBE-AAF579281751

P698

Q37754665-E4953170-C81A-45E2-91CB-7D0ADA92C830

P921

Q37754665-5D0E946F-FE47-4F04-A98B-A453E99866FF

P356

1744666X.3.5.781

P1433

Expert Review of Clinical Immunology

P1476

Emerging biologics in the treatment of uveitis.

@en

P2093

Steven Yeh

http://www.w3.org/2001/XMLSchema#string

P2860

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolong

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

Monoclonal antibodies against CD54 (ICAM-1) and CD11a (LFA-1) prevent and inhibit endotoxin-induced uveitis

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

The biology of chemokines and their receptors

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.

P304

781-796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/1744666X.3.5.781

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Robert B Nussenblatt

Grace A Levy-Clarke

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20477028

http://www.w3.org/2001/XMLSchema#string

P921